Activity of T-1106 in a hamster model of yellow fever virus infection

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 6, 2007, Pages 1962-1966

  Julander, Justin G ^a   Furuta, Yousuke ^b   Shafer, Kristiina ^a   Sidwell, Robert W ^a  

^a UTAH STATE UNIVERSITY   (United States)

^b TOYAMA CHEMICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CONSENSUS INTERFERON; PYRAZINE DERIVATIVE; RIBAVIRIN; T 1106; T 705; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEATH; DOSE RESPONSE; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; FEMALE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS INFECTION; VIRUS TITRATION; WEIGHT GAIN; YELLOW FEVER FLAVIVIRUS;

AMIDES; ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; CRICETINAE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MESOCRICETUS; PYRAZINES; TREATMENT OUTCOME; VERO CELLS; YELLOW FEVER; YELLOW FEVER VIRUS;

EID: 34250179837     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01494-06     Document Type: Article

References (18)

1. Arroyo, J. I., S. A. Apperson, C. B. Cropp, B. J. Marafino, Jr., T. P. Monath, R. B. Tesh, R. E. Shope, and M. A. Garcia-Blanco. 1988. Effect of human gamma interferon on yellow fever virus infection. Am. J. Trop. Med. Hyg. 38:647-650.
2. Bae, H. G., C. Drosten, P. Emmerich, R. Colebunders, P. Hantson, S. Pest, M. Parent, H. Schmitz, M. A. Warnat, and M. Niedrig. 2005. Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium. J. Clin. Virol. 33:274-280.
3. Furuta, Y., K. Takahashi, Y. Fukuda, M. Kuno, T. Kamiyama, K. Kozaki, N. Nomura, H. Egawa, S. Minami, Y. Watanabe, H. Narita, and K. Shiraki. 2002. In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob. Agents Chemother. 46:977-981.
4. Furuta, Y., K. Takahashi, M. Kuno-Maekawa, H. Sangawa, S. Uehara, K. Kozaki, N. Nomura, H. Egawa, and K. Shiraki. 2005. Mechanism of action of T-705 against influenza virus. Antimicrob. Agents Chemother. 49:981-986.
5. Furuta, Y., K. Takahashi, M. Maekawa, H. Maegawa, H. Egawa, and N. Terashima. 2004. T-1106, a novel pyrazine nucleoside, hepatitis C virus polymerase inhibitor, abstr. F-487, p. 27. Abstr. 44th Intersci. Conf. Antimicrob. Agents Chemother.
6. Julander, J. G., J. D. Morrey, L. M. Blatt, K. Shafer, and R. W. Sidwell. 2007. Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model. Antivir. Res. 73:140-146.
7. McFarland, J. M., L. M. Baddour, J. E. Nelson, S. K. Elkins, R. B. Craven, B. C. Cropp, G. J. Chang, A. D. Grindstaff, A. S. Craig, and R. J. Smith. 1997. Imported yellow fever in a United States citizen. Clin. Infect. Dis. 25:1143-1147.
8. Monath, T. P. 2005. Yellow fever vaccine. Expert Rev. Vaccines 4:553-574.
9. Monath, T. P., J. Arroyo, I. Levenbook, Z.-X. Zhang, J. Catalan, K. Draper, and F. Guirakhoo. 2002. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines. J. Virol. 76:1932-1943.
10. Petersen, L. R., and A. A. Marfin. 2005. Shifting epidemiology of Flaviviridae. J. Travel Med. 12(Suppl. 1):S3-S11.
11. Quaresma, J. A., V. L. Barros, C. Pagliari, E. R. Fernandes, F. Guedes, C. F. Takakura, H. F. Andrade, Jr., P. F. Vasconcelos, and M. I. Duarte. 2006. Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF-beta, TNF-alpha and NK cells activity. Virology 345:22-30.
12. Sbrana, E., S. Y. Xiao, H. Guzman, M. Ye, A. P. Travassos da Rosa, and R. B. Tesh. 2004. Efficacy of post-exposure treatment of yellow fever with ribavirin in a hamster model of the disease. Am. J. Trop. Med. Hyg. 71:306-312.
13. Sbrana, E., S. Y. Xiao, V. L. Popov, P. C. Newman, and R. B. Tesh. 2006. Experimental yellow fever virus infection in the golden hamster (Mesocricetus auratus). III. Clinical laboratory values. Am. J. Trop. Med. Hyg. 74:1084-1089.
14. Sidwell, R. W., D. L. Barnard, C. W. Day, D. F. Smee, K. W. Bailey, M. H. Wong, J. D. Morrey, and Y. Furuta. 2007. Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. Antimicrob. Agents Chemother. 51:845-851. (Epub 28 December 2006.)
15. Sidwell, R. W., and J. H. Huffman. 1971. Use of disposable micro tissue culture plates for antiviral and interferon induction studies. Appl. Microbiol. 22:797-801.
16. Tesh, R. B., H. Guzman, A. P. da Rosa, P. F. Vasconcelos, L. B. Dias, J. E. Bunnell, H. Zhang, and S. Y. Xiao. 2001. Experimental yellow fever virus infection in the Golden hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies. J. Infect. Dis. 183:1431-1436.
17. Tomori, O. 2004. Yellow fever: the recurring plague. Crit. Rev. Clin. Lab. Sci. 41:391-427.
18. Xiao, S. Y., H. Zhang, H. Guzman, and R. B. Tesh. 2001. Experimental yellow fever virus infection in the Golden hamster (Mesocricetus auratus). II. Pathology. J. Infect. Dis. 183:1437-1444.